Industry Update View All
Is There a Light at the End of the Tunnel for SCLC?

Small-cell lung cancer (SCLC) is an aggressive lung cancer subtype with neuroendocrine differentiation diagnosed in more than 150,000 individuals globally each year. The 3-year survival rate for patients with extensive stage (ES) SCLC is around 6%, ...

Dr. Mohsin RoshanJun 21, 2024
Challenges and Strategies for Managing CHB Patients with Co-morbidities

With the widespread implementation of vaccination programs and the development of potent antiviral therapies against chronic hepatitis B (CHB) virus infection in recent decades, the risk of horizontal and vertical transmission is decreasing. Accordi...

Dr. Roy LauJun 21, 2024
Arrival of New Era for Aesthetic Medicine with Letibotuliniumtoxin A

Injection with botulinum toxin type A (BoNT-A) remains one of the most common treatments for both males and females. Interestingly, since 2021, there had been 6.2 million cosmetic procedures performed with BoNT-A and staggering 3.1 million of these ...

Dr. Mohsin RoshanJun 19, 2024
FeaturedView All